Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
AMVUTTRA (vutrisiran) is the first and only silencer RNA therapy for treating both ATTR cardiomyopathy (ATTR CM) and hereditary ATTR polyneuropathy (hATTR PN) in adults. It is given as just four injections per year and has been shown to reduce heart-related death and hospital visits for ATTR CM, while improving nerve function for hATTR PN.
Parse Score